|
|
Article: Sanofi-aventis Completes Acquisition of Merck's Interest in Merial.
- Article from:
- Business Wire
- Article date:
- September 18, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PARIS & WHITEHOUSE STATION, N.J. -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Merck & Co., Inc. (NYSE: MRK) today announced that the acquisition by sanofi-aventis of Merck's 50 percent interest in Merial Limited (Merial) has been completed.
Sanofi-aventis acquired Merck's interest in Merial for a cash consideration of $4 billion (US). Formed in 1997, Merial is a leading animal health company that was a 50/50 joint venture between Merck and sanofi-aventis and is now a wholly-owned subsidiary of sanofi-aventis.
As per the terms of the agreement signed on July 29, 2009, sanofi-aventis also has an option, following the closing of the ...